Swiss National Bank Emergent Bio Solutions Inc. Transaction History

Swiss National Bank

$146 Billion
Q4 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$7.35 - $13.21 $13,230 - $23,778	1,800 Added 1.86%	98,700 $725,000
Q1 2023 May 10, 2023	SELL	$7.79 - $16.29 $80,237 - $167,787	-10,300 Reduced 9.61%	96,900 $1 Million
Q3 2022 Nov 09, 2022	SELL	$20.09 - $35.8 $36,162 - $64,439	-1,800 Reduced 1.65%	107,200 $2.25 Million
Q2 2022 Aug 09, 2022	SELL	$27.42 - $43.63 $150,810 - $239,965	-5,500 Reduced 4.8%	109,000 $3.38 Million
Q1 2022 May 09, 2022	BUY	$36.48 - $52.22 $291,840 - $417,760	8,000 Added 7.51%	114,500 $4.7 Million
Q3 2021 Nov 08, 2021	BUY	$50.07 - $66.05 $40,056 - $52,840	800 Added 0.76%	106,500 $5.33 Million
Q2 2021 Aug 06, 2021	BUY	$56.61 - $80.46 $152,847 - $217,241	2,700 Added 2.62%	105,700 $6.66 Million
Q1 2021 May 07, 2021	BUY	$86.23 - $125.19 $112,099 - $162,747	1,300 Added 1.28%	103,000 $9.57 Million
Q4 2020 Feb 05, 2021	BUY	$79.17 - $111.47 $55,419 - $78,029	700 Added 0.69%	101,700 $9.11 Million
Q3 2020 Nov 09, 2020	BUY	$81.91 - $134.94 $188,393 - $310,362	2,300 Added 2.33%	101,000 $10.4 Million
Q2 2020 Aug 05, 2020	BUY	$54.33 - $89.52 $738,888 - $1.22 Million	13,600 Added 15.98%	98,700 $7.81 Million
Q1 2020 May 08, 2020	BUY	$49.34 - $68.76 $59,208 - $82,512	1,200 Added 1.43%	85,100 $4.92 Million
Q4 2019 Feb 06, 2020	BUY	$51.21 - $59.06 $81,936 - $94,496	1,600 Added 1.94%	83,900 $4.53 Million
Q3 2019 Nov 12, 2019	BUY	$40.6 - $57.2 $52,780 - $74,360	1,300 Added 1.6%	82,300 $4.3 Million
Q2 2019 Aug 02, 2019	BUY	$39.92 - $53.86 $83,832 - $113,106	2,100 Added 2.66%	81,000 $3.91 Million
Q1 2019 May 10, 2019	BUY	$48.23 - $66.16 $178,451 - $244,792	3,700 Added 4.92%	78,900 $3.99 Million
Q4 2018 Feb 13, 2019	BUY	$55.63 - $73.24 $111,260 - $146,480	2,000 Added 2.73%	75,200 $4.46 Million
Q2 2018 Aug 09, 2018	BUY	$48.33 - $55.64 $584,793 - $673,244	12,100 Added 19.8%	73,200 $3.7 Million
Q1 2018 May 04, 2018	BUY	$44.44 - $54.39 $106,656 - $130,536	2,400 Added 4.09%	61,100 $3.22 Million
Q4 2017 Feb 07, 2018	BUY	$37.77 - $47.75 $67,986 - $85,950	1,800 Added 3.16%	58,700 $2.73 Million
Q3 2017 Nov 03, 2017	BUY	$34.14 - $40.45 $1.94 Million - $2.3 Million	56,900	56,900 $2.3 Million

Others Institutions Holding EBS

# of Institutions

172

Shares Held

36.8M

Call Options Held

336K

Put Options Held

203K

View Full List

About Emergent BioSolutions Inc.

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $384M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

More about EBS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account